Tissue Regenix Group (TRX)

Sector:

Financials

Index:

FTSE AIM All-Share

62.50p
   
  • Change Today:
    -0.50p
  • 52 Week High: 71.50
  • 52 Week Low: 49.00
  • Currency: UK Pounds
  • Shares Issued: 70.57m
  • Volume: 2,827
  • Market Cap: £44.11m
  • RiskGrade: 22

Tissue Regenix strikes distribution deal in Italy

By Josh White

Date: Wednesday 09 Mar 2022

LONDON (ShareCast) - (Sharecast News) - Medical device company Tissue Regenix has signed an exclusive distribution agreement with Geistlich Biomaterials Italia, it announced on Wednesday, for the distribution of 'OrthoPure XT' in Italy.
The AIM-traded firm said OrthoPure XT, a "decellularised xenograft ligament", uses its patented 'dCell' technology as the only available non-human biologic graft indicated for certain ligament reconstruction procedures.

OrthoPure XT was commercially launched in December 2020 after being awarded a CE mark for revision of anterior cruciate ligament (ACL) reconstruction procedures and the reconstruction of other knee ligaments, including multiligament and primary procedures when the autograft was deemed unacceptable.

The biocompatible implant provides a "biomechanically appropriate" tissue scaffold for cellular repopulation and eventual regeneration, the company explained.

It said the multiyear distribution agreement covered Italy currently, but also had the potential for extension to wider geographies.

As part of the deak, Geistlich committed to advance the clinical science surrounding OrthoPure XT, which would be conducted at "some of the leading institutions" by clinicians in Italy.

"Geistlich is a leader in regenerative products, so our commitments are aligned in delivering innovative products to advance patient care," said chief executive officer Daniel Lee.

"We are excited to work with them to build the clinical experience with OrthoPure XT and introduce this transformative product to the Italian medical community."

At 1327 GMT, shares in Tissue Regenix Group were up 10% at 0.37p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

TRX Market Data

Currency UK Pounds
Share Price 62.50p
Change Today -0.50p
% Change -0.79 %
52 Week High 71.50
52 Week Low 49.00
Volume 2,827
Shares Issued 70.57m
Market Cap £44.11m
RiskGrade 22

TRX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
41.8% below the market average41.8% below the market average41.8% below the market average41.8% below the market average41.8% below the market average
61.9% below the sector average61.9% below the sector average61.9% below the sector average61.9% below the sector average61.9% below the sector average
Price Trend
75.89% above the market average75.89% above the market average75.89% above the market average75.89% above the market average75.89% above the market average
62.07% above the sector average62.07% above the sector average62.07% above the sector average62.07% above the sector average62.07% above the sector average
Income Not Available
Growth
18.07% above the market average18.07% above the market average18.07% above the market average18.07% above the market average18.07% above the market average
11.11% above the sector average11.11% above the sector average11.11% above the sector average11.11% above the sector average11.11% above the sector average

TRX Dividends

No dividends found

Trades for 28-Mar-2024

Time Volume / Share Price
15:40 4 @ 63.00p
15:40 10 @ 62.00p
15:40 75 @ 63.00p
15:40 3 @ 62.00p
15:40 10 @ 62.00p

TRX Key Personnel

CEO Daniel Lee
CFO David Cocke

Top of Page